| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 834.610 | 721.619 | 835.874 | 1.387.182 | 1.561.922 | 510.956 | 457.557 | 655.459 | 709.345 | 781.496 |
| Total Income - EUR | 845.249 | 726.121 | 838.425 | 1.394.428 | 1.571.941 | 511.520 | 460.151 | 661.396 | 711.194 | 783.255 |
| Total Expenses - EUR | 780.117 | 712.232 | 788.132 | 1.310.393 | 1.546.577 | 558.708 | 431.214 | 620.828 | 648.241 | 689.364 |
| Gross Profit/Loss - EUR | 65.132 | 13.890 | 50.293 | 84.036 | 25.365 | -47.188 | 28.937 | 40.568 | 62.953 | 93.891 |
| Net Profit/Loss - EUR | 54.711 | 11.667 | 42.246 | 71.584 | 21.306 | -47.188 | 24.427 | 35.346 | 54.839 | 78.407 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Gral Apotec Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 82.545 | 80.693 | 79.182 | 77.729 | 76.224 | 74.572 | 72.918 | 73.144 | 72.922 | 72.515 |
| Current Assets | 244.148 | 233.851 | 403.341 | 491.166 | 644.403 | 201.592 | 240.502 | 293.410 | 300.613 | 298.914 |
| Inventories | 39.300 | 45.493 | 64.116 | 60.140 | 139.793 | 48.654 | 33.074 | 40.265 | 41.426 | 28.727 |
| Receivables | 132.378 | 119.337 | 291.453 | 370.885 | 490.256 | 142.975 | 146.497 | 229.566 | 189.727 | 222.319 |
| Cash | 72.470 | 69.021 | 47.771 | 60.141 | 14.355 | 9.964 | 60.932 | 23.579 | 69.461 | 47.868 |
| Shareholders Funds | 61.570 | 41.180 | 82.730 | 90.590 | 28.377 | -19.350 | 5.507 | 38.916 | 71.194 | 93.651 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 265.124 | 273.364 | 399.793 | 478.305 | 692.250 | 295.513 | 307.914 | 327.638 | 302.341 | 277.778 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Gral Apotec Srl